Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to transition patients who have been stable on Belatacept for one year after kidney transplant from standard 4-week to an investigational 8-week belatacept dosing schedule. The investigators hypothesize that renal function and acute rejection rates will be non-inferior with 8-week belatacept dosing.
Inclusion criteria
- Kidney Transplantation